329 related articles for article (PubMed ID: 35428019)
21. The Informed Consent Model of Care for Accessing Gender-Affirming Hormone Therapy Is Associated With High Patient Satisfaction.
Spanos C; Grace JA; Leemaqz SY; Brownhill A; Cundill P; Locke P; Wong P; Zajac JD; Cheung AS
J Sex Med; 2021 Jan; 18(1):201-208. PubMed ID: 33249011
[TBL] [Abstract][Full Text] [Related]
22. Changes in depression symptom profile with gender-affirming hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; van den Heuvel OA; Kreukels BPC; van der Tuuk K; T'Sjoen G; den Heijer M; Broekman BFP
J Affect Disord; 2024 Mar; 348():323-332. PubMed ID: 38154588
[TBL] [Abstract][Full Text] [Related]
23. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Gender-Affirming Hormone Therapy on Serum Creatinine in Transgender Individuals.
Maheshwari A; Dines V; Saul D; Nippoldt T; Kattah A; Davidge-Pitts C
Endocr Pract; 2022 Jan; 28(1):52-57. PubMed ID: 34474185
[TBL] [Abstract][Full Text] [Related]
25. Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth.
Green AE; DeChants JP; Price MN; Davis CK
J Adolesc Health; 2022 Apr; 70(4):643-649. PubMed ID: 34920935
[TBL] [Abstract][Full Text] [Related]
26. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
[TBL] [Abstract][Full Text] [Related]
27. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy.
Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM
Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383
[No Abstract] [Full Text] [Related]
28. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
[TBL] [Abstract][Full Text] [Related]
30. Incidence of Type 2 Diabetes Mellitus in Transgender Individuals Undergoing Gender Affirming Hormonal Therapy: A Systematic Review.
Panday P; Ejaz S; Gurugubelli S; Prathi SK; Palou Martinez Y; Arrey Agbor DB; Nath TS
Cureus; 2024 Apr; 16(4):e58137. PubMed ID: 38738018
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy.
Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC
Eur J Prev Cardiol; 2022 Nov; 29(15):2017-2026. PubMed ID: 35778824
[TBL] [Abstract][Full Text] [Related]
32. Internalized transphobia predicts worse longitudinal trend of body uneasiness in transgender persons treated with gender affirming hormone therapy: a 1-year follow-up study.
Castellini G; Rossi E; Cassioli E; Sanfilippo G; Ristori J; Vignozzi L; Maggi M; Ricca V; Fisher AD
J Sex Med; 2023 Feb; 20(3):388-397. PubMed ID: 36763949
[TBL] [Abstract][Full Text] [Related]
33. Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment.
Raven LM; Guttman-Jones M; Muir CA
Endocrine; 2021 May; 72(2):524-528. PubMed ID: 33398769
[TBL] [Abstract][Full Text] [Related]
34. Expanding upon the relationship between gender-affirming hormone therapy, neural connectivity, mental health, and body image dissatisfaction.
Grannis C; Mattson WI; Leibowitz SF; Nahata L; Chen D; Strang JF; Thobe H; Indyk JA; Nelson EE
Psychoneuroendocrinology; 2023 Oct; 156():106319. PubMed ID: 37331310
[TBL] [Abstract][Full Text] [Related]
35. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
Schneider F; Wistuba J; Holterhus PM; Kulle A; Schlatt S; Kliesch S; Neuhaus N; Zitzmann M
J Sex Med; 2021 Oct; 18(10):1807-1817. PubMed ID: 34600646
[TBL] [Abstract][Full Text] [Related]
36. A National Survey of United States-Based Endocrinologists Who Prescribe Gender-Affirming Hormone Therapy.
Bisno DI; Lubitz S; Marshall I; Cohen DA
Endocr Pract; 2023 Jun; 29(6):465-470. PubMed ID: 36906069
[TBL] [Abstract][Full Text] [Related]
37. Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.
Muir CA; Guttman-Jones M; Man EJ
Endocrine; 2024 Feb; ():. PubMed ID: 38386168
[TBL] [Abstract][Full Text] [Related]
38. Body Image and Sexual Desire in the Context of Gender Affirming Therapy: Results of a Cross-sectional Multi-centered Transgender Study.
Garz M; Schröder J; Nieder T; Becker I; Biedermann S; Hildebrandt T; Briken P; Auer M; Fuß J
J Sex Marital Ther; 2021; 47(5):435-445. PubMed ID: 33616008
[TBL] [Abstract][Full Text] [Related]
39. Implications of gender-affirming endocrine care for sports participation.
Moreland E; Cheung AS; Hiam D; Nolan BJ; Landen S; Jacques M; Eynon N; Jones P
Ther Adv Endocrinol Metab; 2023; 14():20420188231178373. PubMed ID: 37323162
[TBL] [Abstract][Full Text] [Related]
40. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
Nguyen HB; Chavez AM; Lipner E; Hantsoo L; Kornfield SL; Davies RD; Epperson CN
Curr Psychiatry Rep; 2018 Oct; 20(12):110. PubMed ID: 30306351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
